Skip to Main Content

Paper Details

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.
Clin Pharmacol Drug Dev
14
2019
Author NameAffiliation
Mihai GheorghiadeCenter for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine
  • 1 - 1

Datasets

Release 1.2